BEONE MEDICINES (06160.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec24

National Medical Insurance Bureau Launches Innovative Drug Directory for Commercial Health Insurance

16:16

Dec13

Macquarie Analyst Maintains Buy Rating on BeiGene

01:12

Dec12

BeiGene Establishes A-Share Raising Fund Management System

09:38

Dec8

UOB Securities Analysts Positive on BeiGene's Revenue Growth Potential

04:37

Dec7

Two Drugs of BeiGene Entered the Commercial Insurance Innovative Drugs Directory

03:19

Dec4

Brokers Adjust Ratings and Target Prices for Multiple Stocks

01:00

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 10.99 B, Net Income 971.6 M, EPS 0.6226

Aug6

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 10.32 B, Net Income 740.4 M, EPS 0.4709

May7

Earning Release(CST)

FY2025 Q1 Earning Release (HKD) Revenue 8.692 B, Net Income 9.88 M, EPS 0.0068

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More